Rare diseases
Investigational molecules
Locations
Back to Italy805 clinical trials in Florence, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Acoramidis for Preventing Transthyretin Amyloidosis in Young People with a Genetic Risk
ItalyStudy on the Safety of Roginolisib and Ruxolitinib for Patients with Myelofibrosis Unresponsive to JAK Inhibitors
ItalyStudy of Rituximab and Golcadomide for Older Frail Patients with Diffuse Large B-cell Lymphoma
ItalyStudy on the Effectiveness of Denosumab with Chemotherapy (Cisplatin, Methotrexate, Doxorubicin) for Patients with Metastatic Osteosarcoma
ItalyItalyStudy on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination
ItalyStudy on Tedopi and Nivolumab for Patients with Advanced Non-Small Cell Lung Cancer After Initial Treatment
ItalyStudy on Avelumab and Cetuximab for Patients with Metastatic Colorectal Cancer Who Have Previously Received Treatment
ItalyStudy of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients
ItalyStudy on the Safety and Effectiveness of Vibrio Alginolyticus Collagenase and Alprostadil for Patients with Peyronie's Disease
ItalyStudy on Cisplatin, Nab-paclitaxel, and Nivolumab with Radiotherapy for Patients with Non-Metastatic Muscle Invasive Bladder Cancer
ItalyStudy of BCG Vaccine and Sodium Chloride for Patients with Radiologically Isolated Syndrome (RIS)
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for frontotemporal dementia, multiple sclerosis, and Dravet syndrome. Studies evaluate novel therapeutic approaches including DNL593 for FTD and frexalimab for relapsing MS.
Emphasis on safety assessment and long-term efficacy monitoring.
Comprehensive studies targeting various cancer types including colorectal cancer, breast cancer, and lung cancer. Trials explore combination therapies and novel treatment approaches.
Focus on targeted therapies and personalized treatment approaches.
Investigating treatments for psoriatic arthritis, Sjögren's syndrome, and systemic sclerosis. Research includes evaluation of new biologics and targeted therapies.
Studies aim to improve quality of life and disease management.
Studies examining treatments for COPD and respiratory infections, including evaluation of tezepelumab for moderate to severe COPD and prevention of RSV in infants.
Focus on improving respiratory outcomes and prevention strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
